Primary cell cultures from 18 human pheochromocytomas were maintained in culture for 10 to 12 days and characterized. The cell yields ranged from 1.0 to 60.1 x lo6 cells/g wet weight of tissue. Cell size, as determined by histofluorescent microscopy, varied as much as seven-fold among cells derived from a given tumor and ten-fold between cells from all tumors. Cell catecholamine content, norepinephrine (NE) plus epinephrine, ranged from 0.4 to 89.5 nmoll lo6 cells at day 5 in culture and did not correlate with catecholamine content of the tissue from which the cells were obtained. Cell catecholamine content decreased with time in culture, but this decrease could not be related to a change in cell viability, the type of media used, an inability to convert dopamine to NE, or an alteration in the uptake of 3H-NE. Cellular uptake of 1.0 pM 'H-NE varied as much as 230-fold between all cell dispersions. The basal and acetylcholine stimulated release of both preloaded 3H-NE and the endogenous catecholamines was quite variable. There was no correlation between the release rate, either basal or stimulated, of preloaded 3H-NE and the endogenous catecholamines. This study represents the largest existing data base on culturing cells from these tumors and describes many of the morphologic and biochemical characteristics of this cell system. Kadin and Bensch, 1971 ). The latter effect appeared to be partially antagonized by the presence of nerve growth factor (Pfragner et al., 1984) . It has also been reported that nerve growth factor induced cell process formation (Tischler et al., 1976; Pfragner and Walser, 1980) ; that these cells exhibited short duration, all-or-nothing action potentials (Tischler et al., 1976) ; that acetylcholine and various ionophores stimulated the release of preloaded 3H-norepinephrine (3H-NE) and endogenous catecholamines as well as opioid peptides (Wilson et al., 1981) ; and that these cells produced neuropeptide Y (Tischler et al., 1985) as well as neurotensin and VIP-like immunoreactivity (Tischler et aI., 1984) . These reports have been sporadic and have examined only one or two cell parameters, usually with cells derived from only one or two tumors.
Primary cell cultures from 18 human pheochromocytomas were maintained in culture for 10 to 12 days and characterized. The cell yields ranged from 1.0 to 60.1 x lo6 cells/g wet weight of tissue. Cell size, as determined by histofluorescent microscopy, varied as much as seven-fold among cells derived from a given tumor and ten-fold between cells from all tumors. Cell catecholamine content, norepinephrine (NE) plus epinephrine, ranged from 0.4 to 89.5 nmoll lo6 cells at day 5 in culture and did not correlate with catecholamine content of the tissue from which the cells were obtained. Cell catecholamine content decreased with time in culture, but this decrease could not be related to a change in cell viability, the type of media used, an inability to convert dopamine to NE, or an alteration in the uptake of 3H-NE. Cellular uptake of 1.0 pM 'H-NE varied as much as 230-fold between all cell dispersions. The basal and acetylcholine stimulated release of both preloaded 3H-NE and the endogenous catecholamines was quite variable. There was no correlation between the release rate, either basal or stimulated, of preloaded 3H-NE and the endogenous catecholamines. This study represents the largest existing data base on culturing cells from these tumors and describes many of the morphologic and biochemical characteristics of this cell system. The investigation of human pheochromocytoma has been confined primarily to in vivo studies (Manger and Gifford, 1977 ; Winkler and Smith, 1972) , while the in vitro investigation of this adrenomedullary tumor has been confined almost exclusively to the PC12 rat cell line (Greene and Tischler, 1982) . Since Costero et al. (1965) observed the pulsations of human pheochromwytoma cells in culture, there have been only 11 other reports using cultured cells from this tumor. The total number of tumors reported cultured to date is 25. These studies have reported the presence of cellular catecholamines (Lamberts et al., 19841, a decline of cellular catecholamines on day 21 compared to day 0 (Tischler et al., 19841 , an erratic decline of catecholamines in the culture medium (Cabana et al., 1964; Nishihira et al., 1980) , and a loss or alteration of storage granules with time in culture (Misugi et al., 1968; Kadin and Bensch, 1971) . The latter effect appeared to be partially antagonized by the presence of nerve growth factor (Pfragner et al., 1984) . It has also been reported that nerve growth factor induced cell process formation (Tischler et al., 1976; Pfragner and Walser, 1980) ; that these cells exhibited short duration, all-or-nothing action potentials (Tischler et al., 1976) ; that acetylcholine and various ionophores stimulated the release of preloaded 3H-norepinephrine (3H-NE) and endogenous catecholamines as well as opioid peptides (Wilson et al., 1981) ; and that these cells produced neuropeptide Y (Tischler et al., 1985) as well as neurotensin and VIP-like immunoreactivity (Tischler et aI., 1984) . These reports have been sporadic and have examined only one or two cell parameters, usually with cells derived from only one or two tumors.
This report presents the largest existing single data base (n = 18) concerned with the morphologic and biochemical characterization of cultured human phewhromocytoma cells. In addition to codirming some previously reported observations, we present the following new observations: 1) a wide range in the cell yield from a spectrum of tumors; 2) a large variation in cell size, not only between but also within tumors; 3) a lack of correlation between tissue and cellular catecholamine content; 4) the kinetics of the decrease of cellular catecholamine content with time in culture and the inability of various media and serum combinations to prevent this decrease; 5 ) the existence of, and variation in, the expression of an NE uptake system; and 6) the expression of different secretory patterns among the different tumor cell cultures. Sigma Chemical Co, St. Louis, MO: Collagenase (Type I, 130 to 250 units/mg; Type V, 300 to 500 units/mg), DNAase (200 to 300 Kuntz unitdmg), trypsin (9,000 to 12,000 BAEE unitdmg), Eevo-NE, Zeuo-epinephrine (E), ascorbic acid, Percoll'", acetylcholine chloride, N-2-hydroxyethylpiperazine-N'-Z-ethanesulfonic acid (HEPES), and cytosine arabinoside;
Vanguard International, Neptune, N J Four-well Nunc Multiwell plates.
All other reagents were analytical grade or higher purity.
Patients and collections of surgical specimens
Tumor tissue was obtained under aseptic conditions from 17 patients during surgery at University Hospital (Ann Arbor, MJJ. One surgical specimen was obtained from a patient at Henry Ford Hospital (Detroit, MI). The ten male patients and eight female patients ranged in age from 10 to 64 years at the time of surgery. Eight of the tumors were extra-adrenal and ten were intra-adrenal. Each tumor was diagnosed as a typical pheochromOcytOma from multiple histological sections by pathologists using accepted morphological criteria.
In the operating room, the intact tumor was placed in a sterile, ice cold Ca2+, M2+-free Locke's solution for transport to pathology, where the tissue was weighed and approximately one-fourth to one-half retained for histologic evaluation. The balance of the tumors (1.5 to 45 g) were transported in the same ice cold, sterile solution to our laboratory. Transit time was usually less than 30 min from the operating room to our laboratory but was one hr when the tumor was obtained from Henry Ford Hospital.
Preparation, maintenance, and characterization of cultured cells Tumor tissue was weighed, freed of connective tissue including capsule, and minced into pieces approximately 2 x 2 mm. The minced tissue was placed in a sterile beaker containing 50 to 100 ml of Ca2', M2+-free Locke's solution and shaken in a Dubnoff metabolic shaker at 125 oscillations per min at 37°C for two 20-min periods to remove red blood cells. Subsequently, the tissue was incubated with a collagenase solution in the Ca2+, M2+-free Locke's solution, for four to six digestions of 40 to 50 min each. The collagenase solution, approximately 0.05%, consisted of two parts of !Pype V collagenase, adjusted to represent a constant activity of 300 units/mg, and one part of Type I collagenase, adjusted to represent a constant activity of 200 unitslmg. After the first digestion with collagenase, we added approximately 15% of a 0.25% trypsin solution to succeeding digestions. The digestion solutions contained 0.05 to 0.10 mg/ml of DNAase. Red blood cells and cellular debris were separated from the tumor cells by isopyncnotic centrifugation on a preformed Percoll'" gradient, which was formed using the parameters of Kilipatrick et al., (1980) . Since we found that forming the gradient with the cells in situ destroyed 50 to 60% of the cells, we added the cellular digest to the top of the gradient before centrifuging them through the gradient at 450g for 10 min. Freshly dispersed cells were plated at densities o€ 0.4 to 0.8 x lo6 cells per well in Nunc Multiwell plates and maintained, except as noted, in MEM supplemented with 15% FCS, penicillin (100 units/ml), and steptomycin (100 pglml). Fibroblast growth was routinely inhibited by the addition of 10 pM cytosine arbinoside. The cells were maintained at 37°C in a humidified incubator (Heraeus) under a C0z:air (595) atmosphere and allowed to adapt to culture for four days prior to starting an experiment. After this adaptation period, the medium was changed every second or third day. At 24 hr prior to commencing an experiment, the medium was replaced with fresh medium without cytosine arabinoside.
In order to determine whether the presence or absence of the anti-mitogen cytosine arabinoside, serum from different species, or more "nutrients" in the medium could effect cellular catecholamine levels, cells from patient 3 were maintained in four different media for 14 days. In this experiment, cells, initially plated in MEM plus FCS with cytosine arabinoside, were either maintained in that medium or changed 12 hr later to (1) MEM plus FCS, (2) MEM D-VAL with 5% plasma derived swine serum, or (3) the Nz medium of Bottenstein and Sat0 (1979) . The latter medium consists of a 1:P mixture of Ham's F12 and Dulbecco's Modified Eagle's supplemented with 15 mM HEPES, 5 pg/ml insulin, 100 pg/ml transferrin, 20 nM progesterone, 100 pM putrescine, and 30 nM selenium.
The cells were examined by several techniques to assess viability, morphologic appearance, cell size, and catecholamine content. Cell viability was greater than 90%, as determined by trypan blue exclusion when the cells were plated and at the time of experiments. We did not observe significant cell lost during the experimental period. Cell loss was determined by centrifuging the "old" medium, removed during medium changes, and counting the number of cells removed at each change. Total cell loss (sum of "live" and "dead" cells) was less than 0.5% at any medium change; therefore, the maximal theoretical cell loss that could occur during a 12-day experimental period would be 2% or less. Calculations based on cell number were not corrected for this small cell loss. In the experiment with different media (Table 11 , when the cell medium was changed at 12 hr, we anticipated that the cells might be loosely attached, but cell loss was less than 0.5%. Since there was no significant cell loss, cell viability, at the time of experimentation, was determined by adding trypan blue directly to the culture wells. General cell morphology was visualized and photographed using an inverted Nikon phase-contrast microscope. Histofluorescent (De La Torre and Surgeon, 1976 ) photomicroscopy (Leitz Ortholane-355 nm excitation and 455 nm emission) was used to assess the purity of the cell preparation and to permit an accurate measurement of pheochromocytoma cell size. Using photomicrographs, 25 to 50 fluorescent, catecholamine containing cells per dispersion were measured. Perchloric acid cell extacts were routinely assayed for E and NE using the differential fluorometric assay technique of Anton and Sayre (1962) . In some experiments, cell dopamine, in addition to E and NE, content was determined using the Cat-A-Kit'", a modification of the radioenzymatic technique of Passon and Peuler (1973) . Prior to mincing the tissue for a cell dispersion, several 100 to 200 mg samples of the tumor were set aside for assay of tissue catecholamine content; the tissue was homogenized with nine volumes of 0.4 N perchloric acid, and the 20,OOOg supernatant was assayed by the differential fluorometric or radioenzymatic assay. Catecholamine content was expressed as nmoV1O' cells and pmolig wet weight tissue.
Incubation conditions for 'H-NE uptake
The uptake protocol and conditions have been described previously (Jaques et al., 1984; Tobes et al., 1985) . Briefly, 4 to 12 days post-dispersion, the tissue culture plates were placed in a 37°C water bath or an ice water bath (0.5 to 1.5"C). Fifteen min prior to commencing the uptake study, the MEM culture medium was removed and the cells were preincubated, at either temperature, with 0.5 ml HEPES buffered Krebs Ringer Glucose (H-KRG), containing 1 mM ascorbic acid adjusted to a final pH of 7.35. Following the pre-incubation, the cells in each well were incubated with 0.30 ml H-KRG containing 1.0 pM 3H-NE. At the end of the incubation period, the plates were placed on ice, the 3H-NE containing H-KRG was removed, and the cells were washed twice. The 3H-NE taken up by the cells was extracted with trichloroacetic acid, which, following the addition of scintillant, was counted in a Beckman LS 7500 liquid scintillation system for 10 min or to a 2 Sigma error of 0.5%.
The 37°C incubations were done in quadruplicate, while the 0°C incubations were done in duplicate. The total uptake was determined by correcting the uptake at 37°C for nonspecific uptake at 0°C. The uptake of 1.0 p M NE at 37°C was linear for 20 min or more in all experiments. Uptake was standardized as pmolil0' cells/ 10 min because cell numbers, as well as the incubation time with different cell preparations, varied. Each experiment was repeated at least once, usually 3 to 5 days after the initial experiment; the results of single experiments are presented. Each data point represents the mean of quadruplicate values f the standard deviation.
In order to determine whether fibroblast "contamination" could significantly effect the estimation of 3H-NE uptake by pheochromocytoma cells, a pure preparation of fibroblasts isolated from a dispersion of the tumor from patient 14 was plated in the Nunc Multiwell plates. Five days later, when the cell monolayer was confluent, the uptake of 3H-NE by these fibroblast cells was determined as described above but was expressed as pmoL' well, since the confluent culture yielded only 67,000 cells/well.
Release of 3H-NE and endogenous catecholamines
At 4 to 12 days post-dispersion, cells were preloaded with 3H-NE by incubating the cells with 0.30 ml H-KRG containing 1.0 pM 3H-NE for a 30-to 45-min period, during which uptake was linear. At the end of this period, the cells were washed twice with one ml of HEPES buffered-Locke's solution and then washed further by incubating for two 10-min periods in fresh Locke's solution (Kilpatrick et al., 1980) . Following the removal of the last wash, the cells were incubated for 10 rnin with 0.64 ml of Lock's solution, either in the presence (stimulated release) or absence (basal release) of 100 p M acetylcholamine. At the end of this period, both cell and media content of 3H-NE were determined. The medium was transferred directly to a scintillation vial, scintillant added, and the mixture counted. The cell radioactivity was extracted with trichloroacetie acid and counted as described above. Release is expressed as a percentage of the total radioactivity within the cell system, i.e., radioactivity recovered in the medium divided by the sum of radioactivity in the medium and cells. The results of a single experiment are presented; each data point represents the mean f the standard deviation. All steps of the experimental protocol, preloading of 3H-NE, washes, and release were carried out at 37°C.
The release of endogenous catecholamines was determined following the same experimental protocol. However, quantitation of cell and medium catecholamines using either of the two catecholamine assays required that the media be made 0.05 N perchloric acid. Therefore, 0.013 ml of 2.5 N perchloric acid was added to the 0.64 ml of the stimulus or basal release solution removed from the incubation well. Cell catecholamines were extracted with 0.5 ml of 0.4 N perchloric acid in Locke's solution, which was then diluted to 0.05 N prior to assay. Standard curves for the fluorometrie assay were generated using authentic E and NE. Cell and medium catecholamine content was calculated as nmoli lo6 cells. Release was expressed as a percentage of the total E and NE in the medium divided by the total within the cell system. Differences between means were determined using Student's t-test.
RESULTS

Cell yield, cell size, and cell morphology
The cell yield from the 18 pheochromocytomas was quite variable; 73% of the tumors yielded 1.0 to 13.8 x lo6 cells/g wet weight of tissue, while the balance yielded 19.5 to 61.6 x lo6 cells/g wet weight of tissue. There was no relationship between the cell yield and the anatomical location of the tumor.
When first plated, the cells appeared as round, individual, phase-dark, epithelial-like cells (Fig. 1A) when visualized with phase contrast microscopy. Cell size, both within and between tumors, varied significantly. A fivefold variation in cell diameter, from the tumor dispersion of patient 1, is observed within a single microscopic field in Fig. 1B ( x 375) . Figure 2 illustrates the variabiliity, and general asymmetric distribution, of cell size (diameter) within six tumors. The cell size distribution in tumors from patients 1 and 11 ( Fig. 2A and 2E ) approximate a normal distribution, although clearly the most common cell sizes were different: 20 to 30 pm for patient 1, but only 10 to 15 pm for patient 11. In contrast, the distribution of cell size in tumors from patients 2, 81 and 15 Pig. 2B, 2D, and 2F respectively) was skewed toward the smaller tumor cells (5 to 10 pm in diameter for patient 8, and 10 to 15 pm in diameter for patients 2 and 15). Tumor cells from patient 5 (Fig. 2C) very non-uniform size distribution and the largest range in cell size (from 10.7 to 47.1 pm in diameter). Examples of the small cells, approximately 5 pm in diameter, as visualized by phase-contrast and histofluorescent microscopy, are indicated with arrows in Fig. 1A and 1B .
The pheochromocytoma cells became firmly attached after three to four days in culture. The round cells frequently coalesced into clumps or groups (Fig. 1C) and flattened somewhat as the cell membranes become less distinct. When pheochromocytoma cells in maintenance and proliferation experiments were maintained in culture for extended periods, they often assumed a polygonal or stellate shape. When pheochromocytoma cells were maintained in culture for 28 days or more, 9 of 17 spontaneously developed long axon-like processes (Fig.  1D) . This occurred as early as 5 days after plating and was delayed for as long as 65 days. Within these nine long-term experiments, the median time to the appearance of processes was 20 days. In these experiments, the appearance of a polygonal or stellate cell conformation, which often preceded the appearance of the axon-like processes, usually occurred at lower plating densities and/or after passaging the cells several times. However, in the "short term" studies reported here, the cells maintained a spherical shape.
Tissue and cell catecholamine content Both tissue and cell catecholamine content, which was predominantly E and NE, varied widely from tumor to tumor. The sum of tissue E plus NE content varied from 0.17 to 77.3 pmol/g wet weight. NE was the principle catecholamine in most tissues and cell extracts. Nine of the ten intra-adrenal pheochromocytomas contained both E and NE, while one contained only NE. Seven of the eight extraadrenal tumors contained only NE, while one had a small amount of E, approximately 1% of the sum. The sum of cell E and NE content varied 224-fold, from 0.4 to 89.5 nmol/106 cells at day 5 in culture. The sum of tissue E and NE varied 326-fold, from 0.2 to 65.2 pmol/g wet weight. However, there was a low correlation (r = 0.636) between tissue and cell content of these catecholamines (Fig. 3) ; the correlation was not improved by the inclusion of cellular dopamine content or when only the NE content of cell and tissue was compared.
The cellular content of catecholamines in cultured tumor cells decreased with time in all cultures. With one exception (Table 1 , patient 31, the decrease in cellular NE content was linear, as illustrated in Figure 4A and 4B. In cells capable of synthesizing E, this catecholamine, without exception, declined linearly with time in culture (Fig. 4B) ; the inability to synthesize E did not change with time in culture (Fig. 4A) . Since the decline of cellular E and NE might have been due to an inability of the cells to hydroxylate dopamine, these levels were measured over the duration of two cultures. The cellular do amine levels were stable, averaging 6.0 & 0. 
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In the cells from patient 3 (Table 11 , the decline in Uptake of 1.0 p M 3H-NE varied more than 230-fold cellular E and NE was not prevented by the presence or (0.2 to 46.2 pmol/106 cells/lO min) between 16 different absence of cytosine arabinoside, or replacement of FCS cell preparations. There was a poor correlation between with the hormonally defined N 2 medium. The decrease 3H-NE uptake and the cellular content of E plus NE in cellular catecholamines was least when the FCS was (Fig. 5) , and E or NE alone (r < 0.243). Additionally, no replaced with plasma-derived swine serum. In none of correlation was found between 3H-NE uptake and the these cultures was the decline in cellular catechol-"most common" cell size (data not shown). Although amines related to a decline in cell viability, which was greater than 90% by trypan blue exclusion at all times. (Fig. 4A) . Uptake of 3H-NE by the cells from patient 1 1 increased nearly 50% between days 5 and 9, while cellular catecholamine levels declined 33% over this same time period (Fig. 4B) . The contribution of contaminating fibroblasts to the determination of 3H-NE uptake by pheochromocytoma cells was assessed by growing isolated fibroblasts from patient 14 to confluence; under these conditions, the uptake of 3H-NE by the fibroblasts was 0.07 pmol/well/lO min, which was significantly less than the uptake of 3H-NE by all but one tumor cell culture.
Uptake and release of 3H-NE-relationship to
Release, either basal or acetylcholine stimulated, of the endogenous catecholamines and preloaded 3H-NE was different between the different cell cultures. The basal and acetylcholine stimulated release of preloaded 3H-NE and endogenous catecholamines from the cells of four tumors is shown in Table 2 . Within these four cell cultures, the basal release of preloaded 3H-NE varied more than ten-fold (3.3 to 36.7%); in fact, the basal release of preloaded 3H-NE from the cells of patient 18
was greater than the stimulated release of preloaded 3H-NE from the cells of the other three tumors. The basal release of endogenous E and NE varied 14-fold, from 1.6 to 22.4%. As with the release of preloaded 3H-N E , the basal release of the endogenous catecholamines from the cells of one tumor (patient 1) was greater than the acetylcholine stimulated release of endogenous catecholamines from the cells of the other three tumors.
Acetylcholine increased the release of preloaded 3H-NE more than six-fold over the basal rate from the cells of patient 9, but it had no stimulatory effect upon the release of preloaded 3H-NE from the cells of patient 13. The acetylcholine stimulated release of endogenous catecholamines also showed a gradation in release; nearly a seven-fold increase from the cells of patient 18 to a very minimal response from the cells of patient 1. There was no consistent parallel between the release, whether basal or acetylcholine stimulated, of preloaded 3H-NE and the endogenous catecholamines.
DISCUSSION
During the past 20 years, only a handful of investiga-
tors have cultured cells from a limited number of human pheochromocytomas. Of the 12 investigations, 9 studied cells from only one or two of these tumors. We have cultured cells from 18 pheochromocytomas and provide new observations and insights on: 1) tumor cell yield, 2) the variation of cell size within and between these tumors, 3) cell morphology in culture, 4) the lack of correlation between cell and tissue catecholamine content, 5) the kinetics of the decrease of cellular catecholamine with time in culture and the inability of different media/ serum combinations to prevent this decrease, 6) the existence and variability in the expression of an NE uptake system, and 7) the variability in basal and acetylcholine stimulated release of endogenous catecholamines and preloaded 3H-NE.
The cell yield from the 18 pheochromocytomas varied more than 70-fold, although it appeared that there were "high" and "low" yield types of tumors. This variability probably reflects the heterogeneity of these tumors, since, in our hands, dispersions of the more homogeneous bovine adrenomedullary tissue exhibit only a twofold variation in cell yield (Jaques and Tobes, unpublished observation) .
Within a given tumor, a diversity of cell size was observed (Fig. 2) . We used histofluorescent microscopy to identify the catecholaminecontaining pheochromocytoma cells and observed a three-to seven-fold variation in cell diameter within tumors. The maximal variation in cell diameter between all tumors was ten-fold 4.8 to 47.1 pm. This represents a far greater variation than reported by Tischler et al. (1976) , which described pheochromocytoma cells as "... 15 to 20 pm in diameter." We found that the "most common" size of cells within a tumor could occur anywhere within the range of cell size for that tumor, i.e., cell size within a tumor seldom followed a Gaussian distribution. In nearly all cell dispersions, five of the six illustrated in Fig. 2 , we observed the occurrence of a population of "small" cells, 5 to 6 pm in diameter, which is the size of the catecholaminecontaining, small, intensely fluorescent (SF) cells located in sympathetic ganglia (Eranko, 1976; Kanerva and Hervonen, 1976) . The significance of the variation of cell size and the presence of a population of "small" cells within these tumors is unknown; the "most common" cell size did not correlate with any of the biochemical characteristics that were examined.
In contrast to other investigators (Pfragner and Walser, 1980; Tischler et al., 1976 Tischler et al., , 1984 Nishihira et al., 19801 , we observed spherical cells more frequently than a polygonal or stellate conformation. Clumping or %01-any" formation of the round, as well as of the stellate cells, occurred frequently. Transformation of the round cells to a polygonal or stellate shape, which was not common, usually occurred after 12 to 30 days in culture and usually preceded the development of axon-like processes. Processes developed in 9 to 17 long term cultures; this occurred as early as day 5 and was delayed for as long as 65 days. We were not able to determine, from a retrospective analysis of the data, whether or not the appearance of the axon-like processes reflected differences in the cell density, number of passages, an interaction with the different substrates (plastic, collagen, or polylysine), nerve growth factor synthesis by fibroblasts eoung et al., 19751, or of the morphologic potential of the cells themselves.
Although differences in pheochromocytoma tissue catecholamine content have been reported (Winkler and Smith, 1968; Blaschko et al., 1968; Wrzolkowa et al., 1975; Feldman et al., 1979; Feldman, 1981) and catecholamine values from five tumors at day 0 were reported (Tischler et al., 1984) , tissue and cell catecholamine levels have not previously been evaluated in parallel. We found that both tissue and cell catecholamine content (E plus NE) varied widely, 326-and 224-fold, respectively, and that there was a poor correlation between cell and tissue content. This lack of correlation was not improved by comparing only E or only NE. Possible explanations for this poor correlation are: 1) the heterogeneity of the tissue relative to the "homogeneity" of the cell preparation; 2) different rates, between tumors, of decline of cellular catecholamines in culture; or 3) changes in the capacity of the cells to synthesize and lor store catecholamines when they are maintained in culture. Dopamine appeared to be a minor component of the total catecholamine content within these cells, and its inclusion in cell catecholamine content did not improve the lack of correlation between tissue and cellular catecholamine content.
The determination of the kinetics of the decline in cellular E and NE with time in culture codirms and expands the report of Tischler et al. (19841, which de- scribed an 87 to 99% decrease in cellular catecholamine content, per culture dish, at day 21 relative to day 0. We explored several possible explanations for the decrease in cellular catecholamines with time in culture. We did not observe a decrease in cell number or viability with time in culture. Tischler et al. (1984) suggested that these factors were partially responsible for the decrease in cellular catecholamines that they observed. It seems likely that the cell loss described by Tischler et al. (1984) is a function of cell density andor cell-to-cell interaction. Our cells were plated at a density of 200,000 to 400,000 cells per cm2. Their cells were plated in petri dishes of unstated size. If it is assumed that they used 35 mm petri dishes, the maximal cell density in any of their cultures would have been 18,000 cells per cm2, a cell density, minimally, 10-to 20-fold less than in our experiments. We have also found that we "lose" cells at these low plating densities.
The stable uptake of 3H-NE over time in culture and the low and relatively stable levels of dopamine with time in culture, which Tischler et al. (1984) also observed, suggests that the time-dependent decrease in cellular E and NE content was not related either to an inability of the cells to take up NE or to convert dopamine to NE. The latter observation is in contrast to the findings in adrenomedullary cell systems when cellular dopamine was found to increase as E and NE declined (Unsicker, 1983) . We also considered the possibility that the decline of cellular catecholamines might be due to: 1) the absence of serum or medium factors required for catecholamine synthesis andor storage; 2) inhibitory factors that might be present in the serums; or 3) cytosine arabinoside, which might inhibit this cell function (Table 1 ). The loss of cellular E and NE when the cells were maintained in MEM plus FCS with or without cytosine arabinoside was similar, indicating that this anti-mitogen had no effect on catecholamine content. The presence of more amino acids, nucleic acids, vitamins, and co-enzymes, or the lack of serum factors in the neuronal specific Nz medium (Bottenstein and Sato, 1979; Bottenstein, 1983) did not affect the rate of catecholamine decline relative to the two MEM plus FCS media. The loss of cellular E and NE was least when the cells were maintained in MEM D-VAL with plasmaderived swine serum, suggesting a species effect of the serum or an inhibitory effect of MEM D-VAL upon fibroblast growth (Gilbert and Migeon, 1975; Dickinson and Slakey, 1982) . However, all of these differences were small and do not suggest a causative association. On the basis of these experiments, it appears that the requirements for maintaining cellular catecholamine levels in culture are quite different than those for maintaining other cell functions such as a stable rate of 3H-NE uptake, the ability to exclude trypan blue, or the ability to synthesize axon-like processes.
Although Anderson et al. (1973) described the in vivo uptake of '*C-dopamine by a presumed catecholamine uptake mechanism in human pheocromocytoma, we provide the first direct evidence of an NE uptake mechanism in this tumor. The expression of this mechanism varied more than 230-fold when uptake was determined at a concentration of 1.0 pM 3H-NE (Fig. 5) . The uptake values at this concentration do not reflect variations in the amount of endogenous cellular NE concurrently secreted into the medium; therefore, the "true" concentration of NE in the medium during the assay may be greater than 1.0 pM. Thus, an underestimation of "real" uptake would be most pronounced in those cells with "high" basal secretion rates. However, it does not appear that basal secretion significantly influenced uptake, since an inverse correlation between high basal secretion and low measured uptake of 3H-NE was not observed (data not shown). We were unable to correlate the 230-fold variation in the rate of 3H-NE uptake with variations in any of the other biochemical parameters examined. The physiologic function, if any, or NE uptake in adrenomedullary and pheochromocytoma cells is not known.
The uptake of 3H-NE by fibroblasts was very low and a minor source of error in all experiments except one. If fibroblasts had grown to total confluency (a process routinely inhibited by the presence of cytosine arabinoside), fibroblast uptake of 3H-NE could have contributed to an over-estimation of uptake by tumor cells by 0.1 to 1.8% in 17 of 18 cell preparations. The determination of 3H-NE uptake by the tumor cells of patient 14 (0.2 pmoV106 cells/lO min) would be over-estimated by 54% if fibroblasts had grown to confluency, i.e., "real" uptake would be 0.2 minus 0.07 pmol/106 cells/lO min.
Our studies demonstrate the expression of different secretory patterns in human pheochromocytoma cells. Normal adrenomedullary cells have a low rate of basal release, typically 3 or 4%. In these cells, acetylcholine, or its nicotinic agonists, normally stimulate release three-to seven-fold above basal levels (Hochman and Perlman, 1976; Lang and Perlman, 1979; Fenwick et al., 1978; Kilpatrick et al., 1980) , and the endogenous catecholamines and preloaded 3H-NE are released in parallel milpatrick et al., 1980; Trifaro and Lee, 1980) . Although our release studies suggest that some similarities to release in normal adrenomedullary cells remain, release from the human pheochromocytoma cells was always different than the release from normal adrenomedullary cells with respect to at least one of the following criteria: 1) elevated basal release, 2) lack of response to acetylcholine, or 3) nonparallel release of endogenous catecholamines and preloaded 3H-NE (Tnblc 2). The basal release of endogenous catecholamines from the cells of patients 9 (3.3%) and 18 (1.7%) was similar to that of "normal" adrenomedullary cells. In contrast, the basal release of endogenous catecholamines in the cells from patients 1 and 13 (22.4 and 12.2%, respectively) was as high or higher than the acetylcholine-stimulated release in the other tumor cells or in normal adrenomedullary cells (Hochman and Perlman, 1976; Lang and Perlman, 1979; Fenwick et al., 1978; Kilpatrick et al., 1980) . Acetylcholine stimulated the release of both the endogenous catecholamines and preloaded 'H-NE in only two of the four dispersions (patients 9 and 19). In the other two cell dispersions, acetylcholine did not stimulate the release of both the preloaded 3H-NE and the endogenous catecholamines, although it caused the release of one or the other. The nonparallel release of the newly sequestered 3H-NE relative to the release of the older, endogenous stores of E and NE in these pheochromocytoma cells was also reported by Wilson et al. (1981) in cells from one tumor and is in contrast to their parallel release in normal bovine adrenomedullary cells (Kilpatrick et al., 1980; Trifaro and Lee, 1980) . These observations suggest that a change in cateholamine storage or release pools is a common occurrence in pheochromocytoma and that this change may be a causative factor in the etiology of the disease. The elevated basal release of some of the cells was consistent with the hypothesis that elevated plasma catecholamines are associated with defective storage or catecholamine synthesis mechanisms (Manger and Gifford, 1977) . However, hyper-secretion by tumors with cells that appear to have "normal" basal secretion and acetylcholine responsiveness must be explained by other, as yet undetermined, mechanisms.
The acetylcholine-stimulated release described here reflects not only activation of nicotinic (Wilson et al., 1981) and/or muscarinic (Koelle, 1970) receptors on the cells, but also the relative rate of metabolism of acetylcholine by each tumor cell culture. Acetylcholinesterase activity has been described in adrenomedullary cells (Mizobe and Livett, 1980) and rat PC12 cells (Greene and Tischler, 19821 , but not in human pheochromocytoma tissue or cells. Although acetylcholinesterase activity may have been present, we did not use an acetylcholinesterase inhibitor because of unpredictable side effects, i.e., 1) these inhibitors may stimulate muscarinic receptors (Taylor, 19801 , and 2) 8 pM eserine actually inhibited acetylcholine-stimulated release of catecholamines from human pheochromocytoma cells (data not shown). A time-dependent increase in acetylcholinesterase activity partially inhibited acetylcholinestimulated release in bovine adrenomedullary cells (Mizobe and Livett, 19801 , and a similar phenomenon could confuse the interpretation of our data. However, it does not appear that time-dependent variations in the activity of a putative acetylcholinesterase are responsible for the different secretory patterns reported here. The cells from patients 1,9, and 13 were of similar age (5, 5, and 8 days respectively), while the cells from patient 18, which were 13 days of age, had the greatest acetylcholine-stimulated release of the endogenous catecholamines (Table 2) .
In summary, we have described 1) a large variation in cell yield bctween tumors; 2) a large variation in cell size, within and between tumors; 3) a lack of correlation between tissue and cellular catecholamine content; 4) the kinetics of the decrease of cellular catecholamine content with time in culture and the inability of various media and serum combinations to prevent this decrease; 5) the existence of and variation in the expression of an NE uptake system; and 6) the expression of different secretory patterns among different tumor cell cultures. These studies should provide a foundation for further biochemical investigation of this tumor.
